Labiotech.eu
Labiotech.eu is an online publication covering the global biotech industry, with a mix of news and in-depth analysis. Updated daily, the site also includes a weekly podcast.
Johnson & Johnson’s hematology portfolio: breakthroughs to watch
Tackling pulmonary fibrosis: Boehringer Ingelheim’s new drug + AI approach
Cracking Cancer’s Code: Transforming Research with Novel Cancer Models
Curing cancer: Daiichi Sankyo's ambitious ADC approach
How to succeed at BIO-Europe: DISCO Pharma takes us behind the scenes
Meet Fusix Biotech: 2025 BIO-Europe Startup Spotlight champion revolutionizing oncology
Next‑generation UTI diagnostics: delivering results in just 35 minutes
How AI Is revolutionizing synthetic biology and biomanufacturing
Pichia pastoris: the microbial protein expression platform you’re probably underestimating
Biotech royalty deals on the rise and here to stay
Contraline's ADAM in the clinic: towards a new era of male contraception?
Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play
What’s next in immunology & inflammation R&D: The trends to watch
BIOSPAIN 2025: Why 1000 companies from more than 40 countries will gather in Barcelona this year
AION Labs is building innovative biotechs with top pharma partners in Israel
Navigating the biotech development journey from first steps to global scale with Lonza
A Finnish biotech is making progress on Parkinson's disease with support from The Michael J. Fox ...
How RNAi is expanding from a therapy of choice for rare disease into treating common conditions
Are next-generation psychedelics the way forward for addressing treatment resistant depression?
Day One DNA: How and why the UK is betting on whole genome sequencing for every newborn
Meatly's innovative cultivated meat is already delighting pets, are humans next?
Cryoport Systems on the state of the ATMP market and the importance of supply chain resilience
InflaRx takes on inflammation with first-in-class C5a/C5aR signaling pathway strategy
How OMass Therapeutics is tackling congenital adrenal hyperplasia, a rare genetic disorder
Persica Pharmaceuticals is treating the cause of chronic lower back pain, not just the symptoms
Humacyte: Saving lives with lab-grown blood vessels in conflict zones
Special Episode: The 2025 BIO International Convention
Alex Telford on AI, drug discovery, digital twins, and the most interesting questions in biotech
Corporate venture capital and biotechnology in 2025: challenges, opportunities, and threats
The state of biotech finance and fundraising in Q2 2025 with Baker McKenzie